[시장보고서]국소 흉터 치료 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 흉터 유형별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

국소 흉터 치료 시장 규모, 점유율, 동향 분석 보고서 : 제품 유형별, 흉터 유형별, 유통 채널별, 지역별, 부문별 예측(2025-2030년)

Topical Scar Treatment Market Size, Share & Trends Analysis Report By Product, By Scar Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

상품코드 : 1611031

리서치사 : Grand View Research

발행일 : 2024년 11월

페이지 정보 : 영문 110 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,833,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,318,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,288,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

국소 흉터 치료 시장 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 국소 흉터 치료 시장 규모는 2030년까지 33억 1,000만 달러에 달할 것으로 추정되며, 2025-2030년까지 11.9%의 CAGR로 성장할 것으로 예상됩니다. 화상, 피부 관련 질환 및 외상의 유병률 증가가 시장 성장의 주요 요인입니다. 외용제는 피부, 모발, 손톱에 적용하도록 설계된 다양한 물질, 화합물, 혼합물이며, 적용 부위에 특정 효과를 발휘하도록 고안된 제품입니다. 스킨케어, 헤어케어 등 퍼스널케어 루틴에 포함되는 경우가 많습니다.

또한, 선진국과 신흥 시장 모두에서 외래 수술 센터의 수용 확대와 흉터 치료를 위한 휴대용 또는 모바일 기기의 도입이 시장을 주도할 것으로 보입니다. 이 시장은 여드름 치료를 위해 특별히 설계된 Q-스위치 레이저 기반 장비인 MedLite C6와 같은 레이저 치료의 채택을 포함하여 상당한 기술적 진보를 보이고 있습니다. 이러한 레이저 장비는 흉터 조직의 파괴를 돕기 때문에 흉터 치료 절차를 간소화할 수 있습니다.

다양한 지역과 국가에서의 흉터 발생을 조사하여 모델을 구축했습니다. 대부분의 환자들이 흉터 관리를 위해 외용제를 선호하는 것으로 관찰되었습니다. 이어 크림, 젤, 실리콘 시트 및 기타 제품의 사용률을 분석했습니다. 또한 제품의 평균 가격, 사용성 및 치료 기간과 같은 요인을 고려하여 시장 규모를 추정하고 제품 유형별로 세분화했습니다.

국소 흉터 치료 시장 보고서 하이라이트

제품별로는 크림이 2024년 36.09%의 매출 점유율로 시장을 주도했습니다. 국소용 크림은 특정 비타민 및 기타 스킨케어 성분을 함유하고 있어 흉터를 눈에 띄지 않게 하는 데 도움이 되어 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.
흉터 유형별로는 위축성 흉터가 37.15%를 차지하며 시장을 주도하고 있습니다. 이 유형의 흉터는 함몰처럼 보이며 일반적으로 포도상 구균 감염, 여드름, 수두, 수술로 인해 발생합니다. 미적 매력에 대한 수요가 증가함에 따라 위축성 흉터 치료를 위한 외용 제품에 대한 수요도 증가하고 있습니다.
2024년, 소매 약국이 40.30%의 매출 점유율로 시장을 독점하고, 정부의 지원과 산업 통합으로 효율성과 비용 효율성이 높아질 것입니다.
2024년 아시아태평양이 44.7%의 매출 점유율로 시장을 장악했습니다. 이 지역의 의료 인프라의 성장, 사람들의 높은 미적 감각, 첨단 제품의 빠른 채택, 고령화 인구의 증가는 시장 지배력에 기여하고 있습니다.

세계의 국소 흉터 치료 시장 : 지역별 대시보드
세계의 국소 흉터 치료 시장 : 지역 변동 분석
세계의 국소 흉터 치료 시장 규모와 예측, 제품, 흉터 유형, 유통 채널, 동향 분석, 2018-2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 인도
- 일본
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

주요 시장 진출 기업의 최근 동향과 영향 분석
기업/경쟁 분류
벤더 상황
- 주요 판매대리점과 채널 파트너 리스트
- 주요 기업의 시장 점유율 분석, 2024년
- Smith &Nephew
- Merz North America, Inc.
- LUMENIS
- Enaltus LLC
- Sonoma Pharmaceuticals, Inc.
- Molnlycke Health Care
- Cynosure, Inc.
- CCA Industries, Inc.
- Scar Heal Inc.
- NewMedical Technology
- Suneva Medical Inc.
- Pacific World Corporation
- Perrigo Company plc

ksm

영문 목차

영문목차

Topical Scar Treatment Market Growth & Trends:

The global topical scar treatment market size is estimated to reach USD 3.31 billion by 2030, registering to grow at a CAGR of 11.9% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing prevalence of burn injuries, skin-related disorders, and trauma are major factors likely to contribute to market growth. Topical products are a variety of substances, compounds, or mixtures that are designed for application on the skin, hair, or nails, with a purpose to exert their effects specifically on the applied area. They are frequently incorporated into routines for personal care, including skincare and haircare.

Moreover, the market is likely to be driven by the growing acceptance of ambulatory surgery centers and introduction of portable or mobile devices for scar treatment in both developed and developing regions. The market has seen significant technological advancements, including the introduction of laser therapies such as the Q-switched laser-based device, MedLite C6, which is specifically designed for treating acne. These laser instruments assist in the breakdown of scar tissue, thereby simplifying scar treatment procedures.

A model was established by examining the occurrence of scars across different regions and countries. It was observed that most patients preferred topical treatments for managing their scars. The usage rates of creams, gels, silicon sheets, and other products were subsequently analyzed. Furthermore, factors such as the average pricing of products, their usability, and the duration of treatment were considered to estimate the market size and allocate the segment division for each type of product.

Topical Scar Treatment Market Report Highlights:

By product, creams dominated the market with a revenue share of 36.09% in 2024. Topical creams have specific vitamins and other skincare ingredients that help reduce a scar's appearance and is expected to positively impact the market growth.
By scar type, atrophic scars dominated the market and accounted for 37.15%. This type of scar looks like a pit and is typically caused by staphylococcus infections, acne, chickenpox, and surgery. As the demand for aesthetic appeal grows, the need for topical products to treat atrophic scars also increases.
Retail pharmacies dominated the market with a revenue share of 40.30% in 2024, driven by government support and industry consolidation, which enhances efficiency and cost-effectiveness.
In 2024, Asia-Pacific dominated the market with a revenue share of 44.7%. The region's growing healthcare infrastructure, high aesthetic consciousness among people, rapid adoption of advanced products, and a growing aging population contributes to the market's dominance

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Scar Type
- 1.2.3. Distribution Channel
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
  - 1.4.5.1. Data for primary interviews in North America
  - 1.4.5.2. Data for primary interviews in Europe
  - 1.4.5.3. Data for primary interviews in Asia Pacific
  - 1.4.5.4. Data for primary interviews in Latin America
  - 1.4.5.5. Data for primary interviews in MEA
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Scar type outlook
- 2.2.3. Distribution channel outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Topical Scar Treatment Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Growing demand for aesthetics
  - 3.2.1.2. Growing number of road accidents and burn cases
  - 3.2.1.3. Growing technological advancements
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Limited effectiveness for severe scars
  - 3.2.2.2. Consumer skepticism and slow adoption
- 3.2.3. Market restraint analysis
  - 3.2.3.1. Growing awareness of skincare and personal appearance
  - 3.2.3.2. Growing popularity of e-commerce
3.3. Topical Scar Treatment Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Environmental landscape
  - 3.3.2.3. Social landscape
  - 3.3.2.4. Technological landscape
  - 3.3.2.5. Legal landscape

Chapter 4. Global Topical Scar Treatment Market: Product Estimates & Trend Analysis

4.1. Topical Scar Treatment Market: Product Dashboard
4.2. Topical Scar Treatment Market: Product Movement Analysis
4.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4. Creams
- 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Gels
- 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Silicon Sheets
- 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.7. Others
- 4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Global Topical Scar Treatment Market: Scar Type Estimates & Trend Analysis

5.1. Topical Scar Treatment Market: Scar Type Dashboard
5.2. Topical Scar Treatment Market: Scar Type Movement Analysis
5.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4. Atrophic Scars
- 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Hypertrophic and Keloid Scars
- 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Contracture Scars
- 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Stretch Marks
- 5.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Global Topical Scar Treatment Market: Distribution Channel Estimates & Trend Analysis

6.1. Topical Scar Treatment Market: Distribution Channel Dashboard
6.2. Topical Scar Treatment Market: Distribution Channel Movement Analysis
6.3. Topical Scar Treatment Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.4. Hospital Pharmacies
- 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Retail Pharmacies
- 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Online
- 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Hypermarkets/ Supermarkets
- 6.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Regional Estimates & Trend Analysis by Product, Scar Type, Distribution Channel

7.1. Global Topical Scar Treatment Market: Regional Dashboard
7.2. Global Topical Scar Treatment Market: Regional Movement Analysis
7.3. Global Topical Scar Treatment Market Size & Forecasts and Trend Analyses by Product, Scar Type, Distribution Channel, 2018 to 2030
7.4. North America
- 7.4.1. U.S.
  - 7.4.1.1. Key country dynamics
  - 7.4.1.2. Regulatory framework/ reimbursement structure
  - 7.4.1.3. Competitive scenario
  - 7.4.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Canada
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework/ reimbursement structure
  - 7.4.2.3. Competitive scenario
  - 7.4.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Mexico
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework/ reimbursement structure
  - 7.4.3.3. Competitive scenario
  - 7.4.3.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
7.5. Europe
- 7.5.1. Germany
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Regulatory framework/ reimbursement structure
  - 7.5.1.3. Competitive scenario
  - 7.5.1.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.2. UK
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/ reimbursement structure
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Spain
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/ reimbursement structure
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework/ reimbursement structure
  - 7.5.4.3. Competitive scenario
  - 7.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework/ reimbursement structure
  - 7.5.5.3. Competitive scenario
  - 7.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Denmark
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework/ reimbursement structure
  - 7.5.6.3. Competitive scenario
  - 7.5.6.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Sweden
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Regulatory framework/ reimbursement structure
  - 7.5.7.3. Competitive scenario
  - 7.5.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Norway
  - 7.5.8.1. Key country dynamics
  - 7.5.8.2. Regulatory framework/ reimbursement structure
  - 7.5.8.3. Competitive scenario
  - 7.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
- 7.6.1. China
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Regulatory framework/ reimbursement structure
  - 7.6.1.3. Competitive scenario
  - 7.6.1.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.2. India
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/ reimbursement structure
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Japan
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework/ reimbursement structure
  - 7.6.3.3. Competitive scenario
  - 7.6.3.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.4. South Korea
  - 7.6.4.1. Key country dynamics
  - 7.6.4.2. Regulatory framework/ reimbursement structure
  - 7.6.4.3. Competitive scenario
  - 7.6.4.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Australia
  - 7.6.5.1. Key country dynamics
  - 7.6.5.2. Regulatory framework/ reimbursement structure
  - 7.6.5.3. Competitive scenario
  - 7.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Thailand
  - 7.6.6.1. Key country dynamics
  - 7.6.6.2. Regulatory framework/ reimbursement structure
  - 7.6.6.3. Competitive scenario
  - 7.6.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
- 7.7.1. Brazil
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Regulatory framework/ reimbursement structure
  - 7.7.1.3. Competitive scenario
  - 7.7.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Argentina
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/ reimbursement structure
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
7.8. MEA
- 7.8.1. South Africa
  - 7.8.1.1. Key country dynamics
  - 7.8.1.2. Regulatory framework/ reimbursement structure
  - 7.8.1.3. Competitive scenario
  - 7.8.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.2. Saudi Arabia
  - 7.8.2.1. Key country dynamics
  - 7.8.2.2. Regulatory framework/ reimbursement structure
  - 7.8.2.3. Competitive scenario
  - 7.8.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.3. UAE
  - 7.8.3.1. Key country dynamics
  - 7.8.3.2. Regulatory framework/ reimbursement structure
  - 7.8.3.3. Competitive scenario
  - 7.8.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
- 7.8.4. Kuwait
  - 7.8.4.1. Key country dynamics
  - 7.8.4.2. Regulatory framework/ reimbursement structure
  - 7.8.4.3. Competitive scenario
  - 7.8.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2024
- 8.3.4. Smith & Nephew
  - 8.3.4.1. Company overview
  - 8.3.4.2. Financial performance
  - 8.3.4.3. Product benchmarking
  - 8.3.4.4. Strategic initiatives
- 8.3.5. Merz North America, Inc.
  - 8.3.5.1. Company overview
  - 8.3.5.2. Financial performance
  - 8.3.5.3. Product benchmarking
  - 8.3.5.4. Strategic initiatives
- 8.3.6. LUMENIS
  - 8.3.6.1. Company overview
  - 8.3.6.2. Financial performance
  - 8.3.6.3. Product benchmarking
  - 8.3.6.4. Strategic initiatives
- 8.3.7. Enaltus LLC
  - 8.3.7.1. Company overview
  - 8.3.7.2. Financial performance
  - 8.3.7.3. Product benchmarking
  - 8.3.7.4. Strategic initiatives
- 8.3.8. Sonoma Pharmaceuticals, Inc.
  - 8.3.8.1. Company overview
  - 8.3.8.2. Financial performance
  - 8.3.8.3. Product benchmarking
  - 8.3.8.4. Strategic initiatives
- 8.3.9. Molnlycke Health Care
  - 8.3.9.1. Company overview
  - 8.3.9.2. Financial performance
  - 8.3.9.3. Product benchmarking
  - 8.3.9.4. Strategic initiatives
- 8.3.10. Cynosure, Inc.
  - 8.3.10.1. Company overview
  - 8.3.10.2. Financial performance
  - 8.3.10.3. Product benchmarking
  - 8.3.10.4. Strategic initiatives
- 8.3.11. CCA Industries, Inc.
  - 8.3.11.1. Company overview
  - 8.3.11.2. Financial performance
  - 8.3.11.3. Product benchmarking
  - 8.3.11.4. Strategic initiatives
- 8.3.12. Scar Heal Inc.
  - 8.3.12.1. Company overview
  - 8.3.12.2. Financial performance
  - 8.3.12.3. Product benchmarking
  - 8.3.12.4. Strategic initiatives
- 8.3.13. NewMedical Technology
  - 8.3.13.1. Company overview
  - 8.3.13.2. Financial performance
  - 8.3.13.3. Product benchmarking
  - 8.3.13.4. Strategic initiatives
- 8.3.14. Suneva Medical Inc.
  - 8.3.14.1. Company overview
  - 8.3.14.2. Financial performance
  - 8.3.14.3. Product benchmarking
  - 8.3.14.4. Strategic initiatives
- 8.3.15. Pacific World Corporation
  - 8.3.15.1. Company overview
  - 8.3.15.2. Financial performance
  - 8.3.15.3. Product benchmarking
  - 8.3.15.4. Strategic initiatives
- 8.3.16. Perrigo Company plc
  - 8.3.16.1. Company overview
  - 8.3.16.2. Financial performance
  - 8.3.16.3. Product benchmarking
  - 8.3.16.4. Strategic initiatives

한글목차

국소 흉터 치료 시장 성장과 동향

국소 흉터 치료 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 국소 흉터 치료 시장 변수, 동향, 범위

제4장 세계의 국소 흉터 치료 시장 : 제품별, 추정·동향 분석

제5장 세계의 국소 흉터 치료 시장 : 흉터 유형별, 추정·동향 분석

제6장 세계의 국소 흉터 치료 시장 : 유통 채널별, 추정·동향 분석

제7장 제품, 흉터 유형, 유통 채널에 의한 지역별, 추정·동향 분석